Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest growing market for anti-asthmatics and COPD drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-asthmatics and COPD drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anti-asthmatics and COPD drugs market, and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by drug class, segmentation by end-user, segmentation by distribution channel, segmentation by therapy, segmentation by route of administration, segmentation by age group, segmentation by prescription and segmentation by drug type.
Market Characteristics – The market characteristics section of the report defines and explains the anti-asthmatics and COPD drugs market. This chapter also defines and describes products and related services covered in the report.
Supply Chain –The supply chain section of the report defines and explains the key players in the anti-asthmatics and COPD drugs industry supply chain.
Product Analysis –The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
Top 10 Leading Drugs Sales –The section describes list of top 10 drugs and their sales in the anti-asthmatics and COPD drug market in 2020. It briefs on the drug chemical composition, drug class and the manufacturers involved in manufacturing and selling of these leading drugs in the anti-asthmatics and COPD drugs market.
Patent Analysis Of Leading Drugs –The section briefs on the patent analysis of the leading drugs in the anti-asthmatics and COPD drugs market, by focusing on the leading drugs’ patent expiry and emergence of the generic drugs in the market.
Customer Information – This chapter covers recent customers’ trends/preferences in the global anti-asthmatics and COPD drugs market.
Impact Of COVID-19 – This section describes the impact of COVID-19 on the anti-asthmatics and COPD drugs market.
Regulatory Landscape – This section describes the regulatory bodies and regulations on the anti-asthmatics and COPD drugs market.
Trends And Strategies – This chapter describes the major trends shaping the global anti-asthmatics and COPD drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Asthma And COPD Prevalence Overview–This section describes about asthma and COPD and their prevalence in the major countries.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
Global Macro Comparison – The global anti-asthmatics and COPD drugs market comparison with macro-economic factors gives the anti-asthmatics and COPD drugs market size, percentage of GDP, and average anti-asthmatics and COPD drugs market expenditure.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global anti-asthmatics and COPD drugs market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background – This section describes the respiratory diseases drugs market of which the anti-asthmatics and COPD drugs market is a segment. This chapter includes the respiratory diseases drugs market 2015-23 values, and regional analyses for the respiratory diseases drugs market.
Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-asthmatics and COPD drugs providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs
2) By End User: Asthma Patients; COPD Patients
3) By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers
4) By Age Group: Below 5 Years; 5 To 14 Years; 15-60 Years; Above 60 Years
5) By Therapy: Preventive; Curative
6) By Route Of Administration: Inhaled; Intravenous; Subcutaneous; Oral
7) By Prescription: Prescription; OTC
8) By Drug Type: Branded; Generics
Companies Mentioned: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer-Ingelheim GmbH; F. Hoffmann-La Roche Ltd; Novartis AG
Metrics Covered: Number of Enterprises; Number of Employees; Per Capita Expenditure
Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; UK; Germany; France; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; Anti-Asthmatics And COPD Drugs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1. Anti-Asthmatics And COPD Drugs Market Executive Summary
- 2. Table of Contents
- 3. List of Figures
- 4. List of Tables
- 5. Report Structure
- 6. Introduction
- 6.1. Segmentation By Geography
- 6.2. Segmentation By Drug Class
- 6.3. Segmentation By End User
- 6.4. Segmentation By Distribution Channel
- 6.5. Segmentation By Therapy
- 6.6. Segmentation By Route Of Administration
- 6.7. Segmentation By Age Group
- 6.8. Segmentation By Prescription
- 6.9. Segmentation By Drug Type
- 7. Anti-Asthmatics And COPD Drugs Market Characteristics
- 7.1. Market Segmentation By Drug Class
- 7.1.1. Bronchodilators
- 7.1.2. Anti-Inflammatory Drugs
- 7.1.3. Monoclonal Antibodies
- 7.1.4. Combination Drugs
- 7.2. Market Segmentation By End User
- 7.2.1. Asthma Patients
- 7.2.2.COPD Patients
- 7.3. Market Segmentation By Distribution Channel
- 7.3.1. Hospital Pharmacies
- 7.3.2. General Pharmacies
- 7.3.3. Online Retailers
- 7.4. Market Segmentation By Therapy
- 7.4.1. Preventive
- 7.4.2. Curative
- 7.5. Market Segmentation By Route Of Administration
- 7.5.1. Oral
- 7.5.2. Inhaled
- 7.5.3. Intravenous
- 7.5.4. Subcutaneous
- 7.6. Market Segmentation By Age Group
- 7.6.1. Below 5
- 7.6.2. 5-14
- 7.6.3. 15-60
- 7.6.4. Above 60
- 7.7. Market Segmentation By Prescription
- 7.7.1. Prescription
- 7.7.2. Over The Counter (OTC)
- 7.8. Market Segmentation By Drug Type
- 7.8.1. Branded
- 7.8.2.Generic
- 8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis
- 8.1.1.Raw Material And Equipment Procurement
- 8.1.2. Manufacturing, Processing and Packaging
- 8.1.3.Distribution
- 8.1.4. Physicians
- 8.1.5.End users
- 9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
- 10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales
- 10.1.1. Ellipta
- 10.1.2. Symbicort
- 10.1.3. Spiriva
- 10.1.4. Advair
- 10.1.5. Nucala
- 10.1.6. Xolair
- 10.1.7. Ventolin
- 10.1.8. Pulmicort
- 10.1.9. Fasenra
- 10.1.10. Flovent
- 11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs
- 11.1.1. Background
- 11.1.2. Innovators
- 12. Anti-Asthmatics And COPD Drugs Market, Customer Information
- 12.1. Challenges Faced By Asthma Patients During COVID-19 Pandemic
- 12.2. COVID-19 Impact On Asthma-Related Quality Of Life
- 12.3. Asthma Patients Attitude Towards Cannabis
- 12.4. Availability And Affordability Of Asthma And COPD Drugs In Nigeria
- 12.5. Majority Of Australian COPD Patients Are Physically Inactive And Obese
- 12.6. Britons Experience Inadequate Treatment Of COPD
- 12.7.COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers
- 12.8. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits
- 12.9. Uncontrolled Asthma Patients Struggle With Mobility Issues
- 13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market
- 13.1.Consumer Perception
- 13.2. COVID-19 Impact On Asthma Patients
- 13.3.Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment
- 13.4. New Drugs Developments and Pilot Studies
- 13.5.Future Outlook
- 14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
- 14.1.1. India
- 14.1.2. China
- 14.1.3. Japan
- 14.1.4. Australia
- 14.1.5. South Korea
- 14.1.6. Indonesia
- 14.1.7. USA
- 14.1.8. Canada
- 14.1.9. Mexico
- 14.1.10. UK
- 14.1.11. Germany
- 14.1.12. France
- 14.1.13. Russia
- 14.1.14. Brazil
- 15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
- 15.1.Use Of Probiotics To Treat Asthma
- 15.2. Anti-IL-5 Treatment For Patients With Severe Asthma
- 15.3.New Product Launches
- 15.4. Bioelectric Medicine For Asthma Patients
- 15.5.Collaborations In The Anti-Asthmatics and COPD Drugs Market
- 15.6. Increasing Demand For Personalized Medicines
- 15.7. Demand For Aerosol Respiratory Drugs
- 15.8. Use Of Biomarker For Precision Medicine
- 15.9. Rise Of Generic Respiratory Drugs
- 15.10. Combination Drug Therapy To Treat COPD
- 15.11. New Biologic Therapy Medicines To Treat Severe Asthma
- 16. Asthma And COPD Prevalence Overview
- 16.1. Asthma
- 16.2. COPD
- 17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth
- 17.1. Market Size
- 17.2.Historic Market Growth, 2015 – 2020, Value ($ Million)
- 17.2.1. Drivers Of The Market 2015 – 2020
- 17.2.2. Restraints On The Market 2015 – 2020
- 17.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 17.3.1. Drivers Of The Market 2020 – 2025
- 17.3.2. Restraints On The Market 2020 – 2025
- 18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis
- 18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19. Global Anti-Asthmatics And COPD Drugs Market Segmentation
- 19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19.1.1. Combination Drugs
- 19.1.2. Bronchodilators
- 19.1.3. Monoclonal Antibodies
- 19.1.4. Anti-Inflammatory Drugs
- 19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19.2.1. Asthma Patients
- 19.2.2. COPD Patients
- 19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020, Value ($ Million)
- 19.4.1. Preventive
- 19.4.2. Curative
- 19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020, Value ($ Million)
- 19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020, Value ($ Million)
- 19.6.1. 15-69 Years
- 19.7.Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020, Value ($ Million)
- 19.7.1. Prescription
- 19.7.2. OTC
- 19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020, Value ($ Million)
- 19.8.1. Branded
- 19.8.2. Generics
- 20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
- 20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
- 20.1.1. Region Information
- 20.1.2. Market Information
- 20.1.3. COVID-19 Impact
- 20.1.4. Background Information
- 20.1.5. Government Initiatives
- 20.1.6. New Drug Trials And Approvals
- 20.1.7. Regulations
- 20.1.8. Regulatory Bodies
- 20.1.9. Major Associations
- 20.1.10. Taxes Levied
- 20.1.11. Corporate Tax Structure
- 20.1.12. Investments
- 20.1.13. Major Companies
- 20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis
- 20.7. China Anti-Asthmatics And COPD Drugs Market
- 20.8. China Anti-Asthmatics And COPD Drugs Market Overview
- 20.8.1. Country Information
- 20.8.2. Market Information
- 20.8.3. COVID-19 Impact
- 20.8.4. Background Information
- 20.8.5. Government Initiatives
- 20.8.6. New Drug Trials And Approvals
- 20.8.7. Regulations
- 20.8.8. Regulatory Bodies
- 20.8.9. Major Associations
- 20.8.10. Taxes Levied
- 20.8.11. Corporate Tax Structure
- 20.8.12. Investments
- 20.8.13. Major Companies
- 20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.13. India Anti-Asthmatics And COPD Drugs Market
- 20.14. India Anti-Asthmatics And COPD Drugs Market Overview
- 20.14.1. Country Information
- 20.14.2. Market Information
- 20.14.3. COVID-19 Impact
- 20.14.4. Background Information
- 20.14.5. Government Initiatives
- 20.14.6. New Drug Trials And Approvals
- 20.14.7. Major Associations
- 20.14.8. Regulations
- 20.14.9. Regulatory Bodies
- 20.14.10. Taxes Levied
- 20.14.11. Corporate Tax Structure
- 20.14.12. Investments
- 20.14.13. Major Companies
- 20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.19. Japan Anti-Asthmatics And COPD Drugs Market
- 20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview
- 20.20.1. Country Information
- 20.20.2. Market Information
- 20.20.3. COVID-19 Impact
- 20.20.4. Background Information
- 20.20.5. Government Initiatives
- 20.20.6. New Drug Trials And Approvals
- 20.20.7. Regulations
- 20.20.8. Regulatory Bodies
- 20.20.9. Major Associations
- 20.20.10. Taxes Levied
- 20.20.11. Corporate Tax Structure
- 20.20.12. Investments
- 20.20.13. Major Companies
- 20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.25. Australia Anti-Asthmatics And COPD Drugs Market
- 20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.30. Indonesia Anti-Asthmatics And COPD Drugs Market
- 20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.35. South Korea Anti-Asthmatics And COPD Drugs Market
- 20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21. Western Europe Anti-Asthmatics And COPD Drugs Market
- 21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
- 21.1.1. Region Information
- 21.1.2. Market Information
- 21.1.3. COVID-19 Impact
- 21.1.4. Background Information
- 21.1.5. Government Initiatives
- 21.1.6. New Drug Trials And Approvals
- 21.1.7. Regulations
- 21.1.8. Regulatory Bodies
- 21.1.9. Major Associations
- 21.1.10. Taxes Levied
- 21.1.11. Corporate Tax Structure
- 21.1.12. Major Companies
- 21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
- 21.7.UK Anti-Asthmatics And COPD Drugs Market
- 21.8. UK Anti-Asthmatics And COPD Drugs Market Overview
- 21.8.1. Country Information
- 21.8.2. Market Information
- 21.8.3. COVID-19 Impact
- 21.8.4. Background Information
- 21.8.5. Government Initiatives
- 21.8.6. New Drug Trials And Approvals
- 21.8.7. Regulations
- 21.8.8. Regulatory Bodies
- 21.8.9. Major Associations
- 21.8.10. Taxes Levied
- 21.8.11. Corporate Tax Structure
- 21.8.12. Major Companies
- 21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.13. Germany Anti-Asthmatics And COPD Drugs Market
- 21.14. Germany Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 21.15. Germany Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.18. France Anti-Asthmatics And COPD Drugs Market
- 21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 22. Eastern Europe Anti-Asthmatics And COPD Drugs Market
- 22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
- 22.1.1. Region Information
- 22.1.2. Market Information
- 22.1.3. COVID-19 Impact
- 22.1.4. Background Information
- 22.1.5. Government Initiatives
- 22.1.6. New Drug Trials And Approvals
- 22.1.7. Regulations
- 22.1.8. Regulatory Bodies
- 22.1.9. Major Associations
- 22.1.10. Taxes Levied
- 22.1.11. Corporate Tax Structure
- 22.1.12. Investments
- 22.1.13. Major Companies
- 22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 22.6. Eastern Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
- 22.7. Russia Anti-Asthmatics And COPD Drugs Market
- 22.8. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 22.9. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 22.11. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 23. North America Anti-Asthmatics And COPD Drugs Market
- 23.1. North America Anti-Asthmatics And COPD Drugs Market Overview
- 23.1.1. Region Information
- 23.1.2. Market Information
- 23.1.3. COVID-19 Impact
- 23.1.4. Background Information
- 23.1.5. Government Initiatives
- 23.1.6. New Drug Trials And Approvals
- 23.1.7. Regulations
- 23.1.8. Regulatory Bodies
- 23.1.9. Major Associations
- 23.1.10. Taxes Levied
- 23.1.11. Corporate Tax Structure
- 23.1.12. Investments
- 23.1.13. Major Companies
- 23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis
- 23.7.USA Anti-Asthmatics And COPD Drugs Market
- 23.8. USA Anti-Asthmatics And COPD Drugs Market Overview
- 23.8.1. Country Information
- 23.8.2. Market Information
- 23.8.3. COVID-19 Impact
- 23.8.4. Background Information
- 23.8.5. Government Initiatives
- 23.8.6. New Drug Trials And Approvals
- 23.8.7. Regulations
- 23.8.8. Regulatory Bodies
- 23.8.9. Major Associations
- 23.8.10. Taxes Levied
- 23.8.11. Corporate Tax Structure
- 23.8.12. Investments
- 23.8.13. Major Companies
- 23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 24. South America Anti-Asthmatics And COPD Drugs Market
- 24.1. South America Anti-Asthmatics And COPD Drugs Market Overview
- 24.1.1. Region Information
- 24.1.2. Market Information
- 24.1.3. COVID-19 Impact
- 24.1.4. Background Information
- 24.1.5. Government Initiatives
- 24.1.6. New Drug Trials And Approvals
- 24.1.7. Regulations
- 24.1.8. Regulatory Bodies
- 24.1.9. Major Associations
- 24.1.10. Taxes Levied
- 24.1.11. Corporate Tax Structure
- 24.1.12. Investments
- 24.1.13. Major Comapnies
- 24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis
- 24.7. Brazil Anti-Asthmatics And COPD Drugs Market
- 24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 25. Middle East Anti-Asthmatics And COPD Drugs Market
- 25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
- 25.1.1. Region Information
- 25.1.2. Market Information
- 25.1.3. COVID-19 Impact
- 25.1.4. Background Information
- 25.1.5. New Drug Trials And Approvals
- 25.1.6. Government Initiatives
- 25.1.7. Regulations
- 25.1.8. Regulatory Bodies
- 25.1.9. Major Associations
- 25.1.10. Taxes Levied
- 25.1.11. Corporate Tax
- 25.1.12. Major Companies
- 25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 26. Africa Anti-Asthmatics And COPD Drugs Market
- 26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
- 26.1.1. Region Information
- 26.1.2. Market Information
- 26.1.3. COVID-19 Impact
- 26.1.4. Background Information
- 26.1.5. Government Initiatives
- 26.1.6. Regulations
- 26.1.7. Regulatory Bodies
- 26.1.8. Major Associations
- 26.1.9. Taxes Levied
- 26.1.10. Corporate Tax Structure
- 26.1.11. Investments
- 26.1.12. Major Companies
- 26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape
- 27.1.Company Profiles
- 27.2. GlaxoSmithKline plc.
- 27.2.1. Company Overview
- 27.2.2. Products And Services
- 27.2.3. Business Strategy
- 27.2.4. Financial Overview
- 27.3.AstraZeneca plc.
- 27.3.1. Company Overview
- 27.3.2. Products And Services
- 27.3.3. Business Strategy
- 27.3.4. Financial Overview
- 27.4. Boehringer-Ingelheim GmbH
- 27.4.1. Company Overview
- 27.4.2. Products And Services
- 27.4.3. Business Strategy
- 27.4.4. Financial Overview
- 27.5.F. Hoffmann-La Roche Ltd
- 27.5.1. Company Overview
- 27.5.2. Products And Services
- 27.5.3. Business Strategy
- 27.5.4. Financial Overview
- 27.6. Novartis AG
- 27.6.1. Company Overview
- 27.6.2. Products And Services
- 27.6.3. Business Strategy
- 27.6.4. Financial Overview
- 28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
- 28.1. AstraZeneca Gets US Clearance For Proposed Alexion Acquisition
- 28.2. Roche Acquired Inflazome
- 28.3. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical
- 28.4. ResMed Acquired Propeller Health
- 28.5. Circassia Acquired AstraZeneca’s COPD Treatment Tudorza
- 28.6. RecipharmAB Acquired Sanofi’s Inhalation Contract Manufacturing Business
- 28.7. Mast Therapeutics, Inc. Merged With Savara Inc.
- 28.8. Mylan N.V. Acquired Majority Stake In Meda AB
- 28.9. Vectura Group Merged With Skyepharma
- 28.10. Recordati Acquired Italchimici S.p.A.
- 28.11. Ruthigen, Inc. Merged With Pulmatrix, Inc.
- 29. Market Background: Respiratory Diseases Drugs Market
- 29.1. Respiratory Diseases Drugs Market Characteristics
- 29.1.1. Market Definition
- 29.1.2. Segmentation By Type
- 29.1.3. Anti-Asthmatics And COPD Drugs
- 29.1.4. Cough And Cold Preparations
- 29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)
- 29.3. Global Respiratory Diseases Drugs Market, 2020, By Region, Value ($ Billion)
- 29.4. Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast, By Region
- 30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies
- 30.1. Global Anti-Asthmatics And COPD Drugs Market In 2025 – Countries Offering Most New Opportunities
- 30.2. Global Anti-Asthmatics And COPD Drugs Market In 2025 – Segments Offering Most New Opportunities
- 30.3. Global Anti-Asthmatics And COPD Drugs Market In 2025 – Growth Strategies
- 30.3.1. Market Trend Based Strategies
- 30.3.2. Competitor Strategies
- 31. Global Anti-Asthmatics And COPD Drugs Market Recommendations
- 31.1.Conclusions
- 31.2. Recommendations
- 31.2.1. Product
- 31.2.2. Place
- 31.2.3. Price
- 31.2.4. Promotion
- 31.2.5. People
- 32. Appendix
- 32.1. Market Data Sources
- 32.2. Research Methodology
- 32.3. Currencies
- 32.4. Research Inquiries
- 32.5. The Business Research Company
- 33. Copyright and Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook